Mode
Text Size
Log in / Sign up

Novel TWISTARE MRI technique shows potential for faster quantitative T2 brain mapping in preclinical validationNew MRI technique shows promise for faster, precise brain tissue mapping in lab tests

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: TWISTARE MRI is a preclinical technical development for faster T2 mapping; clinical utility is unproven.

This preclinical validation study assessed TWISTARE (TWo Interleaved Steady-states for T2 and RF Estimation), a novel dual steady-state 3D-GRE MRI technique using interleaved flip angles and small RF phase increments for quantitative T2 and B1 mapping at 7T. The study, conducted in a laboratory/imaging research setting, compared the technique to an unspecified gold-standard method. The population and sample size were not reported.

In phantom experiments, the technique achieved high precision, though specific effect sizes and absolute numbers were not provided. The method demonstrated up to a two-fold reduction in acquisition time. In-vivo results showed comparable precision and similar scan duration to the gold-standard method. No p-values or confidence intervals were reported for these comparisons.

Safety, tolerability, and adverse events were not reported. Key limitations were not explicitly listed in the provided data, and funding or conflicts of interest were not reported. The study's certainty is limited as it is a preclinical validation study involving Bloch simulations, phantom studies, and in-vivo imaging, with no human clinical trial data.

For practice, this technical development offers potential benefits for clinical and research applications, particularly in longitudinal and dynamic studies of brain tissue in conditions like neurodegenerative diseases. However, clinicians should interpret these findings cautiously, as the evidence does not support statements about clinical efficacy, diagnostic accuracy in patients, safety profile, or comparative effectiveness beyond the stated technical metrics. The technique requires validation in clinical trials.

Scientists have created a new MRI scanning technique called TWISTARE. It's designed to measure specific properties of brain tissue, which could help doctors study conditions like multiple sclerosis, Alzheimer's disease, or stroke damage. The method works by taking special measurements during the MRI scan to create detailed maps of brain tissue.

In laboratory testing, researchers found TWISTARE produced very precise measurements in phantom objects (test objects that mimic tissue). The technique also showed it could potentially reduce the time needed to collect this data by up to half. When tested in living systems, it gave results similar to current gold-standard methods while taking about the same amount of scan time.

It's important to understand this research is still in very early stages. All testing so far has been in laboratory settings—not in patients being evaluated for actual medical conditions. We don't know if this method will work reliably for diagnosing diseases or tracking their progression in people. No safety information or patient outcome data is available yet.

For now, this represents a technical step forward in MRI research. If future studies confirm these findings in human patients, it could eventually help make certain brain scans faster while maintaining quality. However, that will require much more research before doctors could consider using it in clinical practice.

What this means for you:
Early lab research shows a new MRI method might scan brain tissue faster, but it hasn't been tested for patient diagnosis yet.

Study Details

Study typePhase1
EvidenceLevel 4
PublishedMar 2026
View Original Abstract ↓
ObjectiveQuantitative T2 mapping plays a critical role in brain imaging for assessing a range of neurological conditions, including neurodegenerative diseases, demyelinating disorders, and cerebrovascular pathologies. Despite its diagnostic potential, implementing quantitative T2 mapping at ultra-high magnetic field strengths ([≥]7T) poses significant challenges. These include elevated specific absorption rate (SAR) and radiofrequency (RF) field inhomogeneities, which can lead to prolonged scan durations and inaccuracies in quantification. Materials and MethodsPhase-based gradient-recalled echo (GRE) techniques have recently emerged as promising rapid acquisition with enhanced sensitivity to T2-related contrast. In this study, we introduce TWISTARE (TWo Interleaved Steady-states for T2 and RF Estimation), a novel dual steady-state 3D-GRE approach that employs interleaved flip angles and small RF phase increments to jointly estimate T2 and B1 maps. By combining two dual-steady-state scans, TWISTARE enables fast, whole-brain quantitative T2 mapping while reducing scan time and mitigating B1-related bias at ultra-high field. ResultsValidation experiments included Bloch simulations, phantom studies and in-vivo imaging. The results demonstrated high precision in phantom experiments, achieving up to a two-fold reduction in acquisition time and achieved precision comparable to the gold-standard method in vivo within a similar scan duration. DiscussionTWISTARE establishes a fast steady-state framework for quantitative neuroimaging at ultrahigh field, offering potential benefits for both clinical and research applications, especially in longitudinal and dynamic studies of brain tissue.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.